Urolithiasis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
Calcium 75% | Calcium 75% | ||
-hyperparathyroidism, hypercalcemia of malignancy, sarcoidosis, increased absorption from gut; thiazide diuretics | -hyperparathyroidism, hypercalcemia of malignancy, sarcoidosis, increased absorption from gut; thiazide diuretics; topiramate, protease inhibitors (indinavir or sulfadiazine) | ||
Struvite 15% | Struvite 15% | ||
| Line 48: | Line 48: | ||
Renal mass (1.4%) | Renal mass (1.4%) | ||
AAA w/or w/o rupture (1.4%)<br> | AAA w/or w/o rupture (1.4%)<br> | ||
== Treatment == | == Treatment == | ||
Revision as of 07:59, 26 July 2011
Type
Calcium 75%
-hyperparathyroidism, hypercalcemia of malignancy, sarcoidosis, increased absorption from gut; thiazide diuretics; topiramate, protease inhibitors (indinavir or sulfadiazine)
Struvite 15%
-Proteus, Klebsiella, Pseudomonas, Staphylococcus
Uric Acid 6%
Pass Rates
Size
4mm ~75%
4-6mm ~50%
>6mm ~10%
Location in Ureter
- Distal ~70%
- Middle ~50%
- Proximal ~20%
Recurrence Rates
1 yr ~33%
5yr ~50%
- Incresing H2O intake decreases rate
- Protease inhibitors and diuretics increases rate
Differential Dx
Cholelithiasis (5%)
Appy (4%)
Pyelonephitis (3%)
Ovarian cyst (2%)
Renal mass (1.4%)
AAA w/or w/o rupture (1.4%)
Treatment
Source
10/07 DONALDSON (adapted from Tintinalli)